BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31464675)

  • 1. One year in review 2019: Sjögren's syndrome.
    Cafaro G; Croia C; Argyropoulou OD; Leone MC; Orlandi M; Finamore F; Cecchettini A; Ferro F; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):3-15. PubMed ID: 31464675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One year in review 2020: comorbidities, diagnosis and treatment of primary Sjögren's syndrome.
    Manfrè V; Cafaro G; Riccucci I; Zabotti A; Perricone C; Bootsma H; De Vita S; Bartoloni E
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):10-22. PubMed ID: 32940212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates on Sjögren's syndrome: from proteomics to protein biomarkers.
    Baldini C; Cecchettini A; Gallo A; Bombardieri S
    Expert Rev Proteomics; 2017 Jun; 14(6):491-498. PubMed ID: 28532233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year in review 2020: pathogenesis of primary Sjögren's syndrome.
    Bombardieri M; Argyropoulou OD; Ferro F; Coleby R; Pontarini E; Governato G; Lucchesi D; Fulvio G; Tzioufas AG; Baldini C
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):3-9. PubMed ID: 33025887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on disease pathogenesis, diagnosis, and management of primary Sjögren's syndrome.
    Wang J; Zhou L; Liu B
    Int J Rheum Dis; 2020 Jun; 23(6):723-727. PubMed ID: 32297483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Extracellular Vesicle Cargo in Sjögren's Syndrome through a SWATH-MS Proteomics Approach.
    Finamore F; Cecchettini A; Ceccherini E; Signore G; Ferro F; Rocchiccioli S; Baldini C
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year in review 2016: Sjögren's syndrome.
    Ferro F; Vagelli R; Bruni C; Cafaro G; Marcucci E; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2016; 34(2):161-71. PubMed ID: 27095672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year in review 2018: Sjögren's syndrome.
    Argyropoulou OD; Valentini E; Ferro F; Leone MC; Cafaro G; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):14-26. PubMed ID: 30156536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren's syndrome, the old and the new.
    Peri Y; Agmon-Levin N; Theodor E; Shoenfeld Y
    Best Pract Res Clin Rheumatol; 2012 Feb; 26(1):105-17. PubMed ID: 22424197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome: one year in review 2022.
    Manfrè V; Chatzis LG; Cafaro G; Fonzetti S; Calvacchi S; Fulvio G; Navarro Garcia IC; La Rocca G; Ferro F; Perricone C; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2211-2224. PubMed ID: 36541236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It's not the same old lupus or Sjögren's any more: one hundred new insights, approaches, and options since 1990.
    Wallace DJ; Linker-Israeli M
    Curr Opin Rheumatol; 1999 Sep; 11(5):321-9. PubMed ID: 10503650
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of histopathological examination of salivary gland biopsies in diagnosis, prognosis and treatment of Sjögren's Syndrome.
    Barone F; Campos J; Bowman S; Fisher BA
    Swiss Med Wkly; 2015; 145():w14168. PubMed ID: 26375728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for Sjögren's syndrome.
    Baldini C; Ferro F; Elefante E; Bombardieri S
    Biomark Med; 2018 Mar; 12(3):275-286. PubMed ID: 29460647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights of the 14th International Symposium in Sjögren's Syndrome.
    Bombardieri M; Baldini C; Alevizos I; Akpek E; Baer AN
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):3-13. PubMed ID: 30156541
    [No Abstract]   [Full Text] [Related]  

  • 15. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
    Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to assess treatment efficacy in Sjögren's syndrome?
    Vissink A; Bootsma H; Kroese FG; Kallenberg CG
    Curr Opin Rheumatol; 2012 May; 24(3):281-9. PubMed ID: 22450393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome.
    Jonsson R; Haga HJ; Gordon TP
    Scand J Rheumatol; 2000; 29(6):341-8. PubMed ID: 11132201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Proteomics of Saliva in Sjögren's Syndrome.
    Katsiougiannis S; Wong DT
    Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sjögren's syndrome: Towards precision medicine].
    Laigle L; Le Dantec C; Soret P; Desvaux E; Hubert S; Foulquier N; Moingeon P; Guedj M; Pers JO
    Med Sci (Paris); 2022 Feb; 38(2):148-151. PubMed ID: 35179468
    [No Abstract]   [Full Text] [Related]  

  • 20. Sjögren's syndrome: one year in review 2023.
    Longhino S; Chatzis LG; Dal Pozzolo R; Peretti S; Fulvio G; La Rocca G; Navarro Garcia IC; Orlandi M; Quartuccio L; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2023 Dec; 41(12):2343-2356. PubMed ID: 38149515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.